Skip to main content
Log in

Genome-Wide Array Analysis Reveals Novel Genomic Regions and Candidate Gene for Intellectual Disability

  • Original Research Article
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

A Correction to this article was published on 21 November 2018

This article has been updated

Abstract

Introduction

Intellectual disability (ID) is often sporadic, and its complex etiology makes clinical diagnosis extremely difficult.

Objective

The aims of this study were to detect copy number variations (CNVs) in patients with ID and to analyze the correlation between pathogenic CNVs and clinical phenotype.

Methods

After cases of ID caused by metabolic dysfunction or environmental factors were excluded, 64 patients with moderate to severe ID were enrolled. Karyotype and single nucleotide polymorphism (SNP) array analyses were performed for all patients. The relationship between CNVs and phenotype was identified with genotype–phenotype comparisons and by searching CNV databases.

Results

Karyotype analysis showed four patients with chromosomal aneuploidy and seven with chromosomal structural abnormality. After excluding the four cases with chromosomal aneuploidy, the remaining 60 cases were analyzed using SNP array. The results revealed 87 CNVs in 45 cases, including 16 pathogenic CNVs in 12 individuals, with a diagnostic yield of 20.0% (12/60). We found large deletions at 16q22.2q23.1 and 3q24q25.32 in two patients, respectively, in whom specific syndromes had not been defined. Our array analysis showed one case carried a 210 kb deletion at 1p21.2p21.3, which included only one coding gene LPPR4, which might be a candidate gene for ID phenotype.

Conclusions

Use of the genome-wide array method can improve the detection rate of CNVs, reveal chromosomal abnormalities that have not been well-characterized by cytology, and provide a new way to locate genes for patients with the ID phenotype. Interpretation of CNVs remains a major challenge. Sharing of CNVs and phenotype information from different laboratories in public databases is important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

  • 21 November 2018

    An Online First version of this article was made available online.

  • 21 November 2018

    An Online First version of this article was made available online.

References

  1. Moeschler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134(3):e903–18. https://doi.org/10.1542/peds.2014-1839.

    Article  PubMed  Google Scholar 

  2. Honeycutt ACH, Homsi al G, Grosse S, Schendel D, Dunlap L. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment: United States, 2003. MMWR Morbidity Mortality Wkly Rep. 2004;53(3):57–9.

    Google Scholar 

  3. Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet. 2003;73(6):1261–70. https://doi.org/10.1086/379977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM, et al. Diagnostic genome profiling in mental retardation. Am J Hum Genet. 2005;77(4):606–16. https://doi.org/10.1086/491719.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, Melotte C, et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet. 2006;43(8):625–33. https://doi.org/10.1136/jmg.2005.039453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, Morales A, et al. Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat. 2007;28(11):1124–32. https://doi.org/10.1002/humu.20581.

    Article  CAS  PubMed  Google Scholar 

  7. Moeschler JB. Genetic evaluation of intellectual disabilities. Semin Pediatr Neurol. 2008;15(1):2–9. https://doi.org/10.1016/j.spen.2008.01.002.

    Article  PubMed  Google Scholar 

  8. Manning M, Hudgins L, Professional P, Guidelines C. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med Off J Am Coll Med Genet. 2010;12(11):742–5. https://doi.org/10.1097/GIM.0b013e3181f8baad.

    Article  CAS  Google Scholar 

  9. Coe BP, Witherspoon K, Rosenfeld JA, van Bon BW, Vulto-van Silfhout AT, Bosco P, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet. 2014;46(10):1063–71. https://doi.org/10.1038/ng.3092.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–64. https://doi.org/10.1016/j.ajhg.2010.04.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gijsbers AC, Lew JY, Bosch CA, Schuurs-Hoeijmakers JH, van Haeringen A, den Hollander NS, et al. A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first. Eur J Hum Genet EJHG. 2009;17(11):1394–402. https://doi.org/10.1038/ejhg.2009.74.

    Article  PubMed  Google Scholar 

  12. Pradeep V, Mohnish S. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond). 2017;17(6):558–61. https://doi.org/10.7861/clinmedicine.17-6-558.

    Article  Google Scholar 

  13. Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77(17):1629–35. https://doi.org/10.1212/WNL.0b013e3182345896.

    Article  CAS  PubMed  Google Scholar 

  14. Vissers LE, Stankiewicz P. Microdeletion and microduplication syndromes. Methods Mol Biol (Clifton, NJ). 2012;838:29–75. https://doi.org/10.1007/978-1-61779-507-7_2.

    Article  CAS  Google Scholar 

  15. Caspersson T, Farber S, Foley GE, Kudynowski J, Modest EJ, Simonsson E, et al. Chemical differentiation along metaphase chromosomes. Exp Cell Res. 1968;49(1):219–22.

    Article  CAS  Google Scholar 

  16. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. Working Group of the American College of Medical Genetics Laboratory Quality Assurance C. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in medicine: official journal of the American College of Medical. Genetics. 2011;13(7):680–5. https://doi.org/10.1097/GIM.0b013e3182217a3a.

    Article  Google Scholar 

  17. Brauer AU, Savaskan NE, Kuhn H, Prehn S, Ninnemann O, Nitsch R. A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting. Nat Neurosci. 2003;6(6):572–8. https://doi.org/10.1038/nn1052.

    Article  CAS  PubMed  Google Scholar 

  18. Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, Kintscher M, et al. Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell. 2009;138(6):1222–35. https://doi.org/10.1016/j.cell.2009.06.050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. van Karnebeek CD, Jansweijer MC, Leenders AG, Offringa M, Hennekam RC. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet EJHG. 2005;13(1):6–25. https://doi.org/10.1038/sj.ejhg.5201279.

    Article  PubMed  Google Scholar 

  20. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin N Am. 1992;39(4):929–43.

    Article  CAS  Google Scholar 

  21. Peters GB, Pertile MD. Chromosome microarrays in diagnostic testing: interpreting the genomic data. Methods Mol Biol (Clifton, NJ). 2014;1168:117–55. https://doi.org/10.1007/978-1-4939-0847-9_8.

    Article  CAS  Google Scholar 

  22. Chen X, Li H, Mao Y, Xu X, Lv J, Zhou L, et al. Subtelomeric multiplex ligation-dependent probe amplification as a supplement for rapid prenatal detection of fetal chromosomal aberrations. Mol Cytogenet. 2014;7(1):96. https://doi.org/10.1186/s13039-014-0096-1.

    Article  PubMed  PubMed Central  Google Scholar 

  23. De Gregori M, Ciccone R, Magini P, Pramparo T, Gimelli S, Messa J, et al. Cryptic deletions are a common finding in “balanced” reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet. 2007;44(12):750–62. https://doi.org/10.1136/jmg.2007.052787.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zhu H, Hu Y, Zhu R, Yang Y, Zhu X, Wang W. A boy with partial trisomy of chromosome 3q24-q28 from paternal balanced insertion and multiple congenital anomalies. Am J Med Genet Part A. 2013;161A:327–30. https://doi.org/10.1002/ajmg.a.35637.

    Article  Google Scholar 

  25. de Volo CP, Alfonsi M, Gatta V, Novelli A, Bernardini L, Fantasia D, Antonucci I, et al. 16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer. Gene. 2012;498(2):328–31. https://doi.org/10.1016/j.gene.2012.01.028.

    Article  CAS  Google Scholar 

  26. Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelenberg M, et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 2015;385(9975):1305–14. https://doi.org/10.1016/S0140-6736(14)61705-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the Genetic Counselling Clinic of Wenzhou Central Hospital for collecting patients’ phenotype information and Prof. Taosheng Huang from Cincinnati Children’s Hospital for revising this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

ST initiated the study, coordinated clinical analyses of patients, and revised the manuscript. XC performed SNP array analyses and Q-PCR, and wrote the manuscript. HL and CC contributed to data collection and processing. XX helped write parts of the manuscript. LZ and YX performed cytogenetic analyses and cytogenetic diagnoses. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Shaohua Tang.

Ethics declarations

Conflict of interest

Xiangnan Chen, Huanzheng Li, Chong Chen, Lili Zhou, Xueqin Xu, Yanbao Xiang and Shaohua Tang have no conflicts of interest.

Funding

This study was funded by Wenzhou public technology and medical projects (Y20140655, Y20170207), Wenzhou technology bureau projects (ZD201302).

Informed Consent

Parents or guardians of the probands signed their written informed consent, which were approved by Dingli Clinical School Ethics Committee of Wenzhou Medical University.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, X., Li, H., Chen, C. et al. Genome-Wide Array Analysis Reveals Novel Genomic Regions and Candidate Gene for Intellectual Disability. Mol Diagn Ther 22, 749–757 (2018). https://doi.org/10.1007/s40291-018-0358-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40291-018-0358-4

Navigation